Navigation Links
Study: Quick responses to influenza outbreaks reduces illness and death
Date:6/10/2008

as long as those institutions that took longer to begin treating people (6.7 vs. 18.3 days). Early intervention also led to far fewer cases (6.2 cases/100 residents vs. 10.5 cases/100 residents) and deaths (0.45 deaths/100 ill residents vs. 3.3 deaths/100 ill residents).

Given the striking benefits of a quick response, the authors recommend the development of strategies that might hasten an intervention. They suggest that facility staff increase their vigilance for diagnosing influenza cases. They also recommend that the process for collecting respiratory specimens for influenza detection be streamlined, with rapid testing and efficient communication of results from the laboratory to the staff.

The outbreaks the researchers studied occurred between 2001-2004, at which time amantadine was the frontline therapy for treatment and prophylaxis of influenza A. Since 2004, there has been increasing influenza resistance to amantadine and neuraminidase inhibitors have become the newest antivirals of choice. Further study is needed to determine whether rapid initiation of chemoprophylaxis with this class of antiviral drugs will result in similar positive impacts.


'/>"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New NH Economic Study: Bush Medicare Cuts Undermine State and Local Economic, Jobs Base
2. New Maine Economic Study: Bush Medicare Cuts Undermine State and Local Economic, Jobs Base
3. Study: Child maltreatment victims lose 2 years of quality of life
4. Study: Doctors not always sure when to treat BP in people with diabetes
5. Study: Doctors Not Always Sure When to Treat Blood Pressure in People With Diabetes
6. Study: Patients 75 years and older with brain tumors may benefit from more aggressive treatment
7. Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks
8. New Study: Texas Seniors 4th Hardest-Hit from Proposed Bush Administration Medicare Cuts
9. Study: Most female child molesters were victims of sexual abuse
10. Study: Kids think eyeglasses make other kids look smart
11. U of M study: Online intervention paramount for reducing HIV in high-risk population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...an cloning could effectively create a replica of a...ate the first cloned human before the end of the y...ian colleague Dr. Severino Antinori has triggered ... cloning banned in an international treaty.// The ...
... the first time, there is reason to believe that a...work. The treatment -- which triggers growth of ne... the arteries -- may provide a viable new option f...ocedures that open blocked arteries and improve bl...
...tudy aimed at settling a long-standing question am...ell as Warfarin, in helping most patients avoid re...rin was more effective but that aspirin was safer....are involved in the final stages of the most commo...
... or human immunodeficiency virus is a retrovirus t...e system T cells. When HIV attacks a cell, the vir... into the nucleus where it inserts itself as part ...ency Syndrome is a collection of 26 clinical condi...
... later a fertilised egg implants in a woman's uter...new research has found.The report in the latest Ne...cise information the timing of implantation - the ...x to 12 days after ovulation, the researchers from...
...hing young children into learning too much too soo...than high achievers, say nursery experts. This set...lead to symptoms of anxiety, such as tantrums and ...rt to their schooling and may revert to bed-wettin...
Other Medicine News:Health News:More about HIV 2Health News:More about HIV 3
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Springer Series editor John Smol receives two prestigious biology awards 8696 1Springer Series editor John Smol receives two prestigious biology awards 8696 2Ethanol production could jeopardize soil productivity 8694 1Ethanol production could jeopardize soil productivity 8694 2Aluminum oxide nanopore beats other materials for DNA analysis 8692 1Aluminum oxide nanopore beats other materials for DNA analysis 8692 2
...developed over Guidants 20-year history, the VOYAG...ion for successful treatment outcomes. It combines...r profile shaft,more flexible markers, and short t...and tortuous anatomy with even greater confidence,...
...developed over Guidants 20-year history, the VOYAG...ion for successful treatment outcomes. It combines...r profile shaft,more flexible markers, and short t...and tortuous anatomy with even greater confidence,...
Tumor Marker AFP
AFP (NTD) Immulite 2500
Medicine Products: